Toronto Conference 2009 Program
The video for this conference is now available online to view. Click here to watch.
Saturday October 24th, 2009 and Sunday October 25th 2009 at the Crown Plaza Toronto Don Valley at 1250 Eglinton East, Toronto,Ontario, Canada M3C 1J3
The hours of this symposium are:
Saturday, 9:00 A.M. – 5:15 P.M. and Sunday, 9:00 A.M. – 1:30 P.M. All meals and snacks from Friday evening through Sunday lunch, including Saturday night, are provided with your registration.
Our theme for this conference is:
NeuroEndocrine Cancers: The Case for Research, Education, and the Expert Team
While our agenda may yet undergo slight modifications we are excited about these topics and our dynamic team of speakers from the medical communities of Canada, United States, Northern Ireland and Europe.
Together, we look forward to making a difference.
Saturday October 24, 2009
| Time | Topic & Speakers |
|---|---|
| 9:00 | Introductory Comments |
| 9:10 | The Expert Team: A Multidisciplinary Approach to Cancer Care Dr. Mary Gospodarowicz Medical Director, Cancer Program, Princess Margaret Hospital and University Health Network, and Regional Vice President of Cancer Care Ontario, Toronto, Ontario |
Session 1: Diagnosis Biomarkers and Non-Surgical Treatments |
|
| Chair: Dr. Al Driedger Department of Nuclear Medicine, London Health Sciences Centre, London, Ontario, Professor Emeritus: Nuclear Medicine, University of Western Ontario, London, Ontario |
|
| 9:35 | The Spectrum of Neuroendocrine Tumours Dr. Simron Singh Medical Oncologist, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario |
| 10:00 | Diagnosis: The Role of Nuclear Medicine Dr. Al Driedger |
| 10:25 | Diagnosis and Surveillance: The Importance of Circulating Markers Dr. Thomas O’Dorisio Professor of Internal Medicine; Director, Neuroendocrine Tumor Clinic Program, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, United States. |
| 10:45 | Coffee Break |
| Session 2: Surgery: The Expert Views | |
Chair: Dr. Sherif Hanna |
|
| 11:00 | Dr. Natalie Coburn Surgical Oncologist, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario and Dr. Daryl Gray: Surgical Oncologist, London Health Sciences Centre, London, Ontario |
| Session 3: Medical and Radiation Therapies | |
| 11:50 | Dr Thomas O’Dorisio Professor of Internal Medicine; Director, Neuroendocrine Tumor Clinic Program, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, United States. |
| 12:15 | Questions and Answers |
| 12:40 | Lunch |
| Session 4: Psychosocial Aspects in the Management of NETS | |
| 1:40 | Quality of Life Issues Dr. Joy Ardill Professor of Medicine, Queens University, Belfast, Northern Ireland; Consultant Clinical Scientist, Royal Victoria Hospital, Belfast Trust, Belfast, Northern Ireland. |
| 2:05 | Patients’ Perspectives on the Difficulties Diagnosing Carcinoid-NeuroEndocrine Tumours: A Qualitative Study Dr. Deana Midmer and Team Associate Professor and Research Scholar, Department of Family and Community Medicine. Faculty of Medicine, University of Toronto, Ontario |
| 2:30 | Question and Answer |
| 2:45 | Coffee Break |
| Session 5: CNETS Research: The 360 from Bench to Bedside Approach | |
| 3:00 | Co-Chairs: Prof. Girish Shah Chief, Laboratory for Skin Cancer Research at the CHUL (CHUQ) Hospital Research, Associate Professor, Faculty of Medicine Laval University, Quebec City, Quebec and Dr. Sylvia Asa Pathologist-in-Chief. Medical Director, Laboratory Medicine Program, University Health Network. Senior Scientist, Ontario Cancer Institute. Professor, Laboratory Medicine and Pathology, University of Toronto, Ontario |
| 3:10 | Molecular Imaging of Neuroendocrine Tumours Dr. Kjell Oberg Professor of Endocrine Oncology, Medical Faculty, Uppsala University Chairman of Centre of Excellence of Endocrine Tumours, University Hospital, Uppsala, Sweden |
| 3:35 | Discovery of Novel Circulating Markers Dr. Joy Ardill Professor of Medicine, Queens University, Belfast, Northern Ireland; Consultant Clinical Scientist, Royal Victoria Hospital, Belfast Trust, Belfast, Northern Ireland. |
| 4:00 | Animal Models of Carcinoid NETs: Opportunities to Examine Therapeutic Options Prof. Girish Shah |
| 4:25 | Cancer Genetics and Predisposition to Disease Dr. Shereen Ezzat Head Endocrine Oncology Site Group, Princess Margaret Hospital University Health Network, Toronto, Ontario |
| 4:50 - 5:15 | Question and Answer |
Sunday, October 25, 2009
| Time | Topic & Speakers |
|---|---|
| Session 5: Identify Best Practices, Build a Strategic Plan for 21st Century NET Patient Care | |
| Co-Chairs: Dr. Al Driedger and Jim Kormos, Vice President, CNETS Canada |
|
| 9:00 | Carcinoid-Neuroendocrine Tumours in 2010: Where have we been, where are we, and where are we going? |
| 9:40 | Four Concurrent Work Groups provide input on focus questions. |
| 11:20 | Coffee break |
| 11:40 | Summary Presentations from the four Work Groups |
| 12:00 | Building a Strategic Vision to promote and create Pan Canadian Centres of NET Excellence |
| 1:00 | Lunch |
CME Credits
ACCREDITATION
This program meets the accreditation criteria of The College of Family Physicians of Canada and has been accredited for up to 8.5 Mainpro-M1 credits.
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, approved by the University of Toronto (8.5 credits)
The Office of Continuing Education and Professional Development, Faculty of Medicine, University of Toronto, designates this educational activity for a maximum of 8.5 Category 1 credits toward American Medical Association Physician's Recognition Award. Each physician should claim only those credits that s/he actually spent in the activity.
As a result of a reciprocal agreement between the EACCME and AMA, European registrants may claim AMA PRA Category 1 as equivalent.
Sponsors
We would like to thank our Sponsors, Novartis, Covidien, Pfizer and Lantheus for making this conference possible.
